Morallos, Nor-ain C.

HRN: 29-35-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
CEFUROXIME 500MG (TAB)
07/17/2026
07/23/2026
PO
500mg
BID
UTI Following Delivery
Checking Final Appropriateness 
07/21/2026
CEFAZOLIN 1GM (VIAL)
07/21/2026
07/21/2026
IV
2gms
PTOR
STAT CS
Remove - Pending Acceptance
07/21/2026
CEFAZOLIN 1GM (VIAL)
07/21/2026
07/24/2026
IVT
2g
Q8 X 3 More Doses
S/p Primary Cs
Remove - Pending Acceptance
07/21/2026
CEFUROXIME 500MG (TAB)
07/21/2026
07/28/2026
PO
500mg
1 Tab BID X 7 Days
S/p Primary Cs
Remove - Pending Acceptance
07/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/21/2026
07/25/2026
IVT
500mg
Q8 C 7 Doses
S/p Primary Cs
Remove - Pending Acceptance
07/21/2026
METRONIDAZOLE 500MG (TAB)
07/21/2026
07/28/2026
PO
500 Mg
1 Tab Q8 X 7 Days
S/p Primary Cs
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: